EC Healthcare provided unaudited consolidated earnings guidance for the year ended 31 March 2023. For the year, company expects a decrease of not more than 61% in profit after tax, a decrease of not more than 20% in EBITDA.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.34 HKD | +3.88% | +12.61% | -22.99% |
Jan. 31 | EC Healthcare Announces Change of Principal Place of Business in Hong Kong, with Effect from 1 February 2024 | CI |
Jan. 24 | EC Healthcare's Overall Sales Volume Rises 7% in Q4 2023 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.99% | 203M | |
-14.20% | 567M | |
+41.52% | 472M | |
+9.91% | 294M | |
-25.53% | 93.09M | |
-4.20% | 80.02M | |
-10.34% | 66.43M | |
-19.67% | 66.28M | |
0.00% | 61.81M | |
-29.63% | 59.55M |
- Stock Market
- Equities
- 2138 Stock
- News EC Healthcare
- EC Healthcare Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 March 2023